Omkar Pharmachem Ltd — Board Meeting, 30-05-2026: Board Meeting
30-05-2026 | 05:42 pm
30-05-2026 | 05:42 pm
Omkar Pharmachem announced a board meeting where it approved financial results for Q4 & FY26. FY26 Total Comprehensive Income surged to ₹27.21 Cr from ₹0.20 Cr last year, largely due to significant gains in investments.
No comments yet. Be the first to comment!
